 Dopaminergic Neurons
"Dopaminergic Neurons" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neurons whose primary neurotransmitter is DOPAMINE.
| Descriptor ID |
D059290
|
| MeSH Number(s) |
A08.675.278 A11.671.270
|
| Concept/Terms |
Dopaminergic Neurons- Dopaminergic Neurons
- Dopaminergic Neuron
- Neuron, Dopaminergic
- Neurons, Dopaminergic
- Dopamine Neurons
- Dopamine Neuron
- Neuron, Dopamine
- Neurons, Dopamine
|
Below are MeSH descriptors whose meaning is more general than "Dopaminergic Neurons".
Below are MeSH descriptors whose meaning is more specific than "Dopaminergic Neurons".
This graph shows the total number of publications written about "Dopaminergic Neurons" by people in this website by year, and whether "Dopaminergic Neurons" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 3 | 0 | 3 | | 2012 | 3 | 1 | 4 | | 2013 | 4 | 0 | 4 | | 2014 | 1 | 0 | 1 | | 2015 | 2 | 2 | 4 | | 2016 | 2 | 1 | 3 | | 2017 | 3 | 0 | 3 | | 2018 | 4 | 1 | 5 | | 2019 | 4 | 0 | 4 | | 2022 | 1 | 2 | 3 | | 2023 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Dopaminergic Neurons" by people in Profiles.
-
Barcomb K, Ford CP. Alterations in neurotransmitter co-release in Parkinson's disease. Exp Neurol. 2023 12; 370:114562.
-
McGovern DJ, Polter AM, Pr?vost ED, Ly A, McNulty CJ, Rubinstein B, Root DH. Ventral tegmental area glutamate neurons establish a mu-opioid receptor gated circuit to mesolimbic dopamine neurons and regulate opioid-seeking behavior. Neuropsychopharmacology. 2023 12; 48(13):1889-1900.
-
Bortz DM, Feistritzer CM, Grace AA. Medial Prefrontal Cortex to Medial Septum Pathway Activation Improves Cognitive Flexibility in Rats. Int J Neuropsychopharmacol. 2023 Jun 23; 26(6):426-437.
-
Amo-Aparicio J, Daly J, H?jen JF, Dinarello CA. Pharmacologic inhibition of NLRP3 reduces the levels of a-synuclein and protects dopaminergic neurons in a model of Parkinson's disease. J Neuroinflammation. 2023 Jun 22; 20(1):147.
-
Rodriguez-Contreras D, Gong S, Lebowitz JJ, Fedorov LM, Asad N, Dore TM, Phillips TJ, Ford CP, Williams JT, Neve KA. Gait Abnormalities and Aberrant D2 Receptor Expression and Signaling in Mice Carrying the Human Pathogenic Mutation DRD2I212F. Mol Pharmacol. 2023 03; 103(3):188-198.
-
Monogue B, Chen Y, Sparks H, Behbehani R, Chai A, Rajic AJ, Massey A, Kleinschmidt-Demasters BK, Vermeren M, Kunath T, Beckham JD. Alpha-synuclein supports type 1 interferon signalling in neurons and brain tissue. Brain. 2022 10 21; 145(10):3622-3636.
-
Bortz DM, Feistritzer CM, Power CC, Grace AA. Medial septum activation improves strategy switching once strategies are well-learned via bidirectional regulation of dopamine neuron population activity. Neuropsychopharmacology. 2022 11; 47(12):2090-2100.
-
Zych SM, Ford CP. Divergent properties and independent regulation of striatal dopamine and GABA co-transmission. Cell Rep. 2022 05 17; 39(7):110823.
-
Chen K, Palagashvili T, Hsu W, Chen Y, Tabakoff B, Hong F, Shih AT, Shih JC. Brain injury and inflammation genes common to a number of neurological diseases and the genes involved in the genesis of GABAnergic neurons are altered in monoamine oxidase B knockout mice. Brain Res. 2022 01 01; 1774:147724.
-
Bantle CM, Rocha SM, French CT, Phillips AT, Tran K, Olson KE, Bass TA, Aboellail T, Smeyne RJ, Tjalkens RB. Astrocyte inflammatory signaling mediates a-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis. Exp Neurol. 2021 12; 346:113845.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|